Objective: The phototherapeutic effects of low level infrared laser irradiation (808 nm) on brain neuronal cell protection after stroke have been presented recently. We previously reported that 710-nm wavelength visible light (VIS) increases total lymphocyte counts in vivo, especially CD4+ T lymphocytes. In this study, we investigated the effects of 710-nm VIS irradiation on neuronal protection and recovery correlating with cellular immunity in stroke rats. Methods: Rats were subjected to 90-min middle cerebral artery occlusion (MCAO) followed by reperfusion and were divided into two groups: irradiation and no irradiation. The irradiation group had been exposed to 710-nm VIS for 3 weeks after MCAO establishment or sham operation. The helper T cell (CD4+) count in the whole blood and infarct volume were measured. Messenger RNA expression levels of IL-4 and IL-10 in peripheral blood mononuclear cells were measured, a histologic study including microglia activation and regulatory T (Treg) cell markers, neurological severity scoring and a parallel bar walking test were all performed. Results: CD4+ cell count was reduced after MCAO but was significantly increased by 710-nm VIS irradiation. The infarct sizes were decreased in the MCAO + irradiation group compared with the MCAO control group. IL-10 mRNA expression and the immunoreactivity of Treg cells were increased in the MCAO + irradiation group compared with the MCAO control group. Increased microglia activation after MCAO was reduced by 710-nm VIS irradiation. The irradiation group also showed improved neurological severity score levels and step fault scores after MCAO. Conclusions: Our data suggest that 710-nm VIS irradiation may activate cellular immunity, reduce brain infarction and ultimately induce functional recovery in a stroke animal model.

Keywords:
Stroke, 710-nm visible light, Helper T lymphocyte, Phototherapy, Functional recovery
1.
Chaudhry H, Lynch M, Schomacker K, Birngruber R, Gregory K, Kochevar I: Relaxation of vascular smooth muscle induced by low-power laser radiation. Photochem Photobiol 1993;58:661–669.
2.
Samoilova KA, Zhevago NA, Petrishchev NN, Zimin AA: Role of nitric oxide in the visible light-induced rapid increase of human skin microcirculation at the local and systemic levels. II. Healthy volunteers. Photomed Laser Surg 2008;26:443–449.
3.
Karu T: Photobiology of low-power laser effects. Health Phys 1989;56:691–704.
4.
Ribeiro MS, Da Silva Dde F, De Araujo CE, De Oliveira SF, Pelegrini CM, Zorn TM, Zezell DM: Effects of low-intensity polarized visible laser radiation on skin burns: a light microscopy study. J Clin Laser Med Surg 2004;22:59–66.
5.
Woo YK, Kwon SY, Lee HS, Park YS: Proliferation of anterior cruciate ligament cells in vitro by photo-immobilized epidermal growth factor. J Orthop Res 2007;25:73–80.
6.
Al-Watban FA: Laser therapy converts diabetic wound healing to normal healing. Photomed Laser Surg 2009;27:127–135.
7.
Tyrrell J, Campbell SM, Curnow A: The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy. J Photochem Photobiol B 2011;103:1–7.
8.
Swislocki A, Orth M, Bales M, Weisshaupt J, West C, Edrington J, Cooper B, Saputo L, Islas M, Miaskowski C: A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Symptom Manage 2010;39:88–99.
9.
Martin WJ, Stoneburner J: Symptomatic relief of herpetic skin lesions utilizing an energy-based approach to healing. Exp Mol Pathol 2005;78:131–134.
10.
Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K: Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 1994;89:1–7.
11.
Forbes D, Culum I, Lischka AR, Morgan DG, Peacock S, Forbes J, Forbes S: Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. Cochrane Database Syst Rev 2009:CD003946.
12.
Okumoto Y, Koyama E, Matsubara H, Nakano T, Nakamura R: Sleep improvement by light in a demented aged individual. Psychiatry Clin Neurosci 1998;52:194–196.
13.
Van Someren EJ, Kessler A, Mirmiran M, Swaab DF: Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 1997;41:955–963.
14.
Swaab DF, Fliers E, Hoogendijk WJ, Veltman DJ, Zhou JN: Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. Prog Brain Res 2000;126:369–396.
15.
Michalon M, Eskes GA, Mate-Kole CC: Effects of light therapy on neuropsychological function and mood in seasonal affective disorder. J Psychiatry Neurosci 1997;22:19–28.
16.
Matthews YJ, Damian DL: Topical photodynamic therapy is immunosuppressive in humans. Br J Dermatol 2010;162:637–641.
17.
Kubasova T, Horvath M, Kocsis K, Fenyo M: Effect of visible light on some cellular and immune parameters. Immunol Cell Biol 1995;73:239–244.
18.
Zhevago NA, Samoilova KA, Obolenskaya KD: The regulatory effect of polychromatic (visible and infrared) light on human humoral immunity. Photochem Photobiol Sci 2004;3:102–108.
19.
Koreck AI, Csoma Z, Bodai L, Ignacz F, Kenderessy AS, Kadocsa E, Szabo G, Bor Z, Erdei A, Szony B, Homey B, Dobozy A, Kemeny L: Rhinophototherapy: A new therapeutic tool for the management of allergic rhinitis. J Allergy Clin Immunol 2005;115:541–547.
20.
Castano AP, Mroz P, Hamblin MR: Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006;6:535–545.
21.
Takezaki S, Omi T, Sato S, Kawana S: Light-emitting diode phototherapy at 630 +/– 3 nm increases local levels of skin-homing T-cells in human subjects. J Nihon Med Sch 2006;73:75–81.
22.
Zhevago NA, Samoilova KA, Calderhead RG: Polychromatic light similar to the terrestrial solar spectrum without its UV component stimulates DNA synthesis in human peripheral blood lymphocytes in vivo and in vitro. Photochem Photobiol 2006;82:1301–1308.
23.
Lim JH, Lee J, Choi J, Hong J, Jhun H, Han J, Kim S: The effects of light-emitting diode irradiation at 610 nm and 710 nm on murine T-cell subset populations. Photomed Laser Surg 2009;27:813–818.
24.
Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R: Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009;15:192–199.
25.
Offner H, Vandenbark AA, Hurn PD: Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009;158:1098–1111.
26.
Yan J, Greer JM, Etherington K, Cadigan GP, Cavanagh H, Henderson RD, O’Sullivan JD, Pandian JD, Read SJ, McCombe PA: Immune activation in the peripheral blood of patients with acute ischemic stroke. J Neuroimmunol 2009;206:112–117.
27.
Urra X, Cervera A, Villamor N, Planas AM, Chamorro A: Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 2009;158:1174–1183.
28.
Vogelgesang A, Grunwald U, Langner S, Jack R, Broker BM, Kessler C, Dressel A: Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008;39:237–241.
29.
Lapchak PA, Salgado KF, Chao CH, Zivin JA: Transcranial near-infrared light therapy improves motor function following embolic strokes in rabbits: an extended therapeutic window study using continuous and pulse frequency delivery modes. Neuroscience 2007;148:907–914.
30.
Lapchak PA, Wei J, Zivin JA: Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke 2004;35:1985–1988.
31.
Detaboada L, Ilic S, Leichliter-Martha S, Oron U, Oron A, Streeter J: Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke. Lasers Surg Med 2006;38:70–73.
32.
Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M, Lampl Y, Streeter J, DeTaboada L, Chopp M: Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 2006;37:2620–2624.
33.
Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, Oron U: Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke 2007;38:1843–1849.
34.
Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, Fisher M, Hacke W, Holt W, Ilic S, Kasner S, Lew R, Nash M, Perez J, Rymer M, Schellinger P, Schneider D, Schwab S, Veltkamp R, Walker M, Streeter J: Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke 2009;40:1359–1364.
35.
Liu Z, Fan Y, Won SJ, Neumann M, Hu D, Zhou L, Weinstein PR, Liu J: Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 2007;38:146–152.
36.
Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, Parsons AA: Functional assessments in mice and rats after focal stroke. Neuropharmacology 2000;39:806–816.
37.
Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, Prass K, Meisel A: Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007;38:770–773.
38.
Chamorro A, Urra X, Planas AM: Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007;38:1097–1103.
39.
Urra X, Chamorro A: Stroke-induced immunodepression is a marker of severe brain damage. Stroke 2010;41:e110, author reply e111.
40.
Haeusler KG, Schmidt WU, Fohring F, Meisel C, Helms T, Jungehulsing GJ, Nolte CH, Schmolke K, Wegner B, Meisel A, Dirnagl U, Villringer A, Volk HD: Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 2008;25:50–58.
41.
Lim JH, Lee J, Lee IS, Kim YJ, Song EY, Choi YS, Yun YM: The effects of daily irradiation with polychromatic visible polarized light on human lymphocyte populations. Photomed Laser Surg 2008;26:361–366.
42.
Samoilova KA, Obolenskaya, KD, Vologdina AV, Snopov SA, Shevchenko EV: Single skin exposure to visible polarized light induces rapid modification of entire circulating blood. I. Improvement of rheologic and immune parameters. Proc SPIE 1998;3569:90–103.
43.
Samoilova KA, Obolenskaya KD, Vologdina AV, Mineeva NV, Romanenko, NY, Balljuzek MF: On the mechanism of the enhancement of wound healing by visible incoherent polarized (VIP) light: improvement of rheologic, transport functions of erythrocytes and activation of leukocytes of the entire circulating blood. Laser Technol 1999;9:40–41.
44.
Roberts JE: Light and immunomodulation. Ann NY Acad Sci 2000;917:435–445.
45.
Leung MC, Lo SC, Siu FK, So KF: Treatment of experimentally induced transient cerebral ischemia with low energy laser inhibits nitric oxide synthase activity and up-regulates the expression of transforming growth factor-beta 1. Lasers Surg Med 2002;31:283–288.
46.
Keller E, Ishihara H, Nadler A, Niederer P, Seifert B, Yonekawa Y, Frei K: Evaluation of brain toxicity following near infrared light exposure after indocyanine green dye injection. J Neurosci Methods 2002;117:23–31.
47.
McCarthy TJ, De Taboada L, Hildebrandt PK, Ziemer EL, Richieri SP, Streeter J: Long-term safety of single and multiple infrared transcranial laser treatments in Sprague-Dawley rats. Photomed Laser Surg 2010;28:663–667.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.